Clinical Trials Browser

Phase 3 × mecobalamin × 90 days × Clear all

NCT05165069 2026-02-02

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Phase 3 Active not recruiting

Breast Neoplasms, Hand-Foot Syndrome